TWO SIGMA INVESTMENTS, LP - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 253 filers reported holding EDITAS MEDICINE INC in Q1 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$9,863,786
+21.5%
1,264,588
+28.2%
0.03%
+35.0%
Q2 2023$8,118,237
+58.0%
986,420
+39.1%
0.02%
+33.3%
Q1 2023$5,139,590
-39.2%
708,909
-25.6%
0.02%
-44.4%
Q4 2022$8,451,389
-31.4%
952,806
-5.4%
0.03%
-35.7%
Q3 2022$12,326,000
+50.3%
1,007,055
+45.3%
0.04%
+55.6%
Q2 2022$8,202,000
-54.2%
693,296
-26.4%
0.03%
-49.1%
Q1 2022$17,919,000
-29.8%
942,092
-2.1%
0.05%
-3.6%
Q4 2021$25,536,000
+64.4%
961,824
+154.4%
0.06%
+57.1%
Q3 2021$15,533,000
+10.7%
378,115
+52.6%
0.04%
+9.4%
Q2 2021$14,031,000
-59.0%
247,721
-69.6%
0.03%
-64.0%
Q1 2021$34,183,000
+509.8%
813,890
+917.9%
0.09%
+456.2%
Q4 2020$5,606,000
-48.1%
79,954
-79.2%
0.02%
-57.9%
Q3 2020$10,808,000
-22.3%
385,179
-18.1%
0.04%
-44.9%
Q2 2020$13,917,000
+85.0%
470,470
+24.0%
0.07%
+13.1%
Q1 2020$7,521,000
-50.5%
379,263
-26.1%
0.06%
+32.6%
Q4 2019$15,197,000
+116.5%
513,232
+66.3%
0.05%
+91.7%
Q3 2019$7,019,000
+59.8%
308,668
+73.9%
0.02%
+60.0%
Q2 2019$4,392,000
+580.9%
177,538
+572.9%
0.02%
+650.0%
Q1 2019$645,000
-80.0%
26,383
-81.4%
0.00%
-84.6%
Q4 2018$3,229,000
+219.7%
141,931
+347.3%
0.01%
+333.3%
Q3 2018$1,010,000
-66.5%
31,730
-62.3%
0.00%
-66.7%
Q2 2018$3,014,00084,1240.01%
Other shareholders
EDITAS MEDICINE INC shareholders Q1 2022
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 54,615$4,897,0002.55%
Capital Impact Advisors, LLC 130,000$9,114,0002.24%
ARK Investment Management 10,125,564$709,903,0001.89%
Nikko Asset Management Americas, Inc. 4,388,143$307,653,0001.75%
Spectrum Planning & Advisory Services Inc. 17,522$1,228,0001.32%
DDD Partners, LLC 79,527$5,576,0001.10%
Brevan Howard Capital Management LP 76,420$5,358,0001.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 538,721$37,770,0000.75%
DC Investments Management, LLC 3,627$254,0000.63%
Haafor (Singapore) Pte. Ltd. 4,761$334,0000.62%
View complete list of EDITAS MEDICINE INC shareholders